187 related articles for article (PubMed ID: 11751993)
21. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
Hundgeburth LC; Wunsch M; Rovituso D; Recks MS; Addicks K; Lehmann PV; Kuerten S
Clin Immunol; 2013 Mar; 146(3):155-64. PubMed ID: 23352967
[TBL] [Abstract][Full Text] [Related]
22. T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis.
Shriver LP; Dittel BN
Am J Pathol; 2006 Sep; 169(3):999-1011. PubMed ID: 16936273
[TBL] [Abstract][Full Text] [Related]
23. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
[TBL] [Abstract][Full Text] [Related]
24. Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis.
Michailidou I; Jongejan A; Vreijling JP; Georgakopoulou T; de Wissel MB; Wolterman RA; Ruizendaal P; Klar-Mohamad N; Grootemaat AE; Picavet DI; Kumar V; van Kooten C; Woodruff TM; Morgan BP; van der Wel NN; Ramaglia V; Fluiter K; Baas F
Acta Neuropathol Commun; 2018 May; 6(1):36. PubMed ID: 29724241
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of experimental autoimmune demyelination in complement-deficient mice.
Nataf S; Carroll SL; Wetsel RA; Szalai AJ; Barnum SR
J Immunol; 2000 Nov; 165(10):5867-73. PubMed ID: 11067947
[TBL] [Abstract][Full Text] [Related]
26. Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis.
Niculescu T; Weerth S; Niculescu F; Cudrici C; Rus V; Raine CS; Shin ML; Rus H
J Immunol; 2004 May; 172(9):5702-6. PubMed ID: 15100315
[TBL] [Abstract][Full Text] [Related]
27. Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats.
Morgan BP; Griffiths M; Khanom H; Taylor SM; Neal JW
Clin Exp Immunol; 2004 Dec; 138(3):430-8. PubMed ID: 15544619
[TBL] [Abstract][Full Text] [Related]
28. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
29. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
Massacesi L; Genain CP; Lee-Parritz D; Letvin NL; Canfield D; Hauser SL
Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
[TBL] [Abstract][Full Text] [Related]
30. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis.
Nikić I; Merkler D; Sorbara C; Brinkoetter M; Kreutzfeldt M; Bareyre FM; Brück W; Bishop D; Misgeld T; Kerschensteiner M
Nat Med; 2011 Apr; 17(4):495-9. PubMed ID: 21441916
[TBL] [Abstract][Full Text] [Related]
31. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
[TBL] [Abstract][Full Text] [Related]
32. [Pathological findings of axonal injury in a rat model of experimental allergic encephalomyelitis].
Wang Y; Lv T; Liu X; Fang M; Liang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):482-6. PubMed ID: 22543126
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice.
Fluiter K; Opperhuizen AL; Morgan BP; Baas F; Ramaglia V
J Immunol; 2014 Mar; 192(5):2339-48. PubMed ID: 24489093
[TBL] [Abstract][Full Text] [Related]
34. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
35. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
Rus H; Cudrici C; Niculescu F
Adv Exp Med Biol; 2006; 586():139-51. PubMed ID: 16893070
[No Abstract] [Full Text] [Related]
36. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
Lev N; Barhum Y; Melamed E; Offen D
Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
[TBL] [Abstract][Full Text] [Related]
37. Demyelination induced by T cell lines and clones specific for myelin basic protein in mice.
Tabira T; Sakai K
Lab Invest; 1987 May; 56(5):518-25. PubMed ID: 2437389
[TBL] [Abstract][Full Text] [Related]
38. Hereditary C6 deficiency in a strain of PVG/c rats.
Leenaerts PL; Stad RK; Hall BM; Van Damme BJ; Vanrenterghem Y; Daha MR
Clin Exp Immunol; 1994 Sep; 97(3):478-82. PubMed ID: 8082303
[TBL] [Abstract][Full Text] [Related]
39. Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease.
Schäffner E; Bosch-Queralt M; Edgar JM; Lehning M; Strauß J; Fleischer N; Kungl T; Wieghofer P; Berghoff SA; Reinert T; Krueger M; Morawski M; Möbius W; Barrantes-Freer A; Stieler J; Sun T; Saher G; Schwab MH; Wrede C; Frosch M; Prinz M; Reich DS; Flügel A; Stadelmann C; Fledrich R; Nave KA; Stassart RM
Nat Neurosci; 2023 Jul; 26(7):1218-1228. PubMed ID: 37386131
[TBL] [Abstract][Full Text] [Related]
40. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Herrero-Herranz E; Pardo LA; Gold R; Linker RA
Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
